Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2018-09-21
BCDABiocardia, Inc.Stertzer Simon HDirP - Purchase$2.43+1,0003,573,0940%+$2,430
M
2018-09-12
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$1.74+1,100714,4420%+$1,914
M
2018-08-29
GNCAGenocea Biosciences, Inc.Siber GeorgeDirP - Purchase$0.61+163,400165,417>999%+$100,174
M
2018-09-19
LIFEAtyr Pharma IncBroadfoot Jill MarieCFOP - Purchase$0.83+64,00090,000+246%+$52,855
M
2018-09-18
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$1.65+700713,3420%+$1,154
2018-09-18
BCDABiocardia, Inc.Stertzer Simon HDirP - Purchase$1.50+5,0003,572,0940%+$7,500
D
2018-09-18
BOLDAudentes Therapeutics, Inc.Patterson Matthew RCEOS - Sale+OE$40.00-12,952171,814-7%-$518,080
M
2018-09-18
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$39.80-7,800871,291-1%-$310,479
D
2018-09-17
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale+OE$76.84-20,148732,613-3%-$1,548,196
D
2018-09-17
NSTGNanostring Technologies IncClarus Lifesciences Ii, L.P.10%S - Sale+OE$15.99-85,8234,036,025-2%-$1,372,310
D
2018-09-17
NSTGNanostring Technologies IncGalakatos NicholasDir, 10%S - Sale+OE$15.99-85,8234,036,025-2%-$1,372,310
D
2018-09-17
RGNXRegenxbio Inc.Vasista VittalCFOS - Sale+OE$74.86-7,500144,783-5%-$561,472
2018-09-17
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale$74.91-7,510333,510-2%-$562,564
DM
2018-09-17
EDITEditas Medicine, Inc.Myer VickeshCTOS - Sale+OE$32.25-7,0000-100%-$225,750
2018-09-18
PTEPolarityte, Inc.Swanson Edward WinslowCOOP - Purchase$17.27+5001,689+42%+$8,633
2018-09-18
PTEPolarityte, Inc.Mann Paul ElliotCFOP - Purchase$17.24+20,000120,000+20%+$344,716
M
2018-09-14
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$1.59+700712,6420%+$1,110
2018-09-14
LIFEAtyr Pharma IncBroadfoot Jill MarieCFOP - Purchase$0.73+26,00026,000New+$19,055
D
2018-09-17
SGMOSangamo Therapeutics, IncYi KathySVP, CFOS - Sale+OE$14.66-5,0007,250-41%-$73,285
2018-09-18
ONSOncobiologics, Inc.Kenyon Lawrence ACEO, Pres, CFO, Treas, SecyS - Sale$0.87-10,10057,213-15%-$8,807
2018-09-14
PTEPolarityte, Inc.Erdtmann Rainer MDirP - Purchase$17.42+6,68081,846+9%+$116,366
2018-09-14
AERIAerie Pharmaceuticals IncRubino Richard JCFOS - Sale$60.00-2383,7360%-$120
2018-09-13
HSKAHeska CorpNapolitano Jason ACOO, Chief Strategist, Sec.S - Sale$111.50-2,50026,974-8%-$278,750
2018-09-13
GNCAGenocea Biosciences, Inc.Alfieri MichaelPrinciple Financial OfficerP - Purchase$0.54+10,00010,000New+$5,400
2018-09-13
AERIAerie Pharmaceuticals IncRubino Richard JCFOS - Sale$60.17-34,512383,738-8%-$2,076,608
D
2018-09-11
BTXBiotime IncAndrews Deborah JDirP - Purchase$2.35+1,60410,000+19%+$3,769
2018-09-10
VYGRVoyager Therapeutics, Inc.Geraghty James ADirP - Purchase$19.39+3,00076,588+4%+$58,170
2018-09-12
VYGRVoyager Therapeutics, Inc.Pierce GlennDirP - Purchase$18.44+5,0005,000New+$92,200
M
2018-09-10
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$1.36+1,600711,9420%+$2,184
D
2018-09-10
RGENRepligen CorpHunt AnthonyCEOS - Sale+OE$57.71-27,566227,451-11%-$1,590,809
D
2018-09-10
BLUEBluebird Bio, Inc.Walsh Jeffrey T.Chief FinancialS - Sale+OE$150.16-1,50035,495-4%-$225,243
2018-09-10
BLUEBluebird Bio, Inc.Mandell JamesDirS - Sale$150.77-1,0001,000-50%-$150,771
D
2018-09-10
CHRSCoherus Biosciences, Inc.Finck Barbara KChief Medical OfficerS - Sale+OE$18.58-1,76037,043-5%-$32,699
D
2018-09-10
VCELVericel CorpMichel Gerard JCFO, VP, Corp. DevelopmentS - Sale+OE$12.35-15,000150,960-9%-$185,250
D
2018-09-07
SGENSeattle Genetics Inc /waHimes Vaughn BChief Technical OfficerS - Sale+OE$76.99-5,000177,329-3%-$384,962
2018-07-27
ATRAAtara Biotherapeutics, Inc.Koppikar UtpalCFOP - Purchase$36.80+2,00047,000+4%+$73,600
2018-09-07
ADAPAdaptimmune Therapeutics PlcViswanathan Ravi10%P - Purchase$1.67+15,000,00094,978,668+19%+$25,000,500
2018-09-07
ADAPAdaptimmune Therapeutics PlcSonsini Peter W.10%P - Purchase$1.67+15,000,00094,978,668+19%+$25,000,500
2018-09-07
ADAPAdaptimmune Therapeutics PlcSandell Scott D10%P - Purchase$1.67+15,000,00094,978,668+19%+$25,000,500
2018-09-07
ADAPAdaptimmune Therapeutics PlcMott David MDir, 10%P - Purchase$1.67+15,000,00094,978,668+19%+$25,000,500
2018-09-07
ADAPAdaptimmune Therapeutics PlcKerins Patrick J10%P - Purchase$1.67+3,000,00082,978,668+4%+$5,000,100
2018-09-07
ADAPAdaptimmune Therapeutics PlcFlorence Anthony A. Jr.10%P - Purchase$1.67+15,000,00094,978,668+19%+$25,000,500
2018-09-07
ADAPAdaptimmune Therapeutics PlcBehbahani AliDirP - Purchase$1.67+12,000,00012,000,000New+$20,000,400
2018-09-07
ADAPAdaptimmune Therapeutics PlcBaskett Forest10%P - Purchase$1.67+15,000,00094,978,668+19%+$25,000,500
2018-09-07
ADAPAdaptimmune Therapeutics PlcBarris Peter J10%P - Purchase$1.67+15,000,00094,978,668+19%+$25,000,500
2018-09-07
ADAPAdaptimmune Therapeutics PlcBarrett M James10%P - Purchase$1.67+3,000,00082,978,668+4%+$5,000,100
2018-09-07
ADAPAdaptimmune Therapeutics PlcNew Enterprise Associates 14, L.P.10%P - Purchase$1.67+3,000,00082,978,668+4%+$5,000,100
M
2018-09-06
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$39.35-7,800879,091-1%-$306,923
2018-09-07
SGMOSangamo Therapeutics, IncJeffs RogerDirP - Purchase$13.56+7,4089,908+296%+$100,487
2018-09-07
SGMOSangamo Therapeutics, IncParker H StewartDirP - Purchase$13.52+2,0005,500+57%+$27,040
D
2018-09-06
SGMOSangamo Therapeutics, IncConner Edward R.SVP, Chief Medical OfficerS - Sale+OE$14.17-5,00010,125-33%-$70,845
D
2018-09-05
BLUEBluebird Bio, Inc.Gregory Philip DChief Scientific OfficerS - Sale+OE$163.02-1,80031,871-5%-$293,441
2018-09-04
DNLIDenali Therapeutics Inc.Ho CaroleChief Medical OfficerS - Sale$19.05-17,500272,765-6%-$333,375
2018-09-04
DNLIDenali Therapeutics Inc.Watts Ryan J.Pres, CEOS - Sale$19.06-18,3332,778,476-1%-$349,427
D
2018-09-04
GILDGilead Sciences IncMartin John CDirS - Sale+OE$74.16-50,0003,017,762-2%-$3,708,034
2018-09-04
AERIAerie Pharmaceuticals IncKopczynski Casey C.Chief Scientific OfficerS - Sale$60.09-11,000147,517-7%-$661,024
M
2018-08-28
ACORAcorda Therapeutics IncScopia Capital Management LP10%S - Sale$28.76-34,2857,106,9550%-$986,141
D
2018-09-04
BLUEBluebird Bio, Inc.Davidson DavidChief Medical OfficerS - Sale+OE$166.64-7,00024,905-22%-$1,166,493
D
2018-09-04
VCELVericel CorpGilman Steven CDirS - Sale+OE$12.03-9,0000-100%-$108,270
2018-09-04
EDITEditas Medicine, Inc.Bosley KatrinePres, CEOS - Sale$32.35-12,0001,252,966-1%-$388,210
2018-09-05
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$1.33+5,000710,342+1%+$6,650
D
2018-09-04
ATRAAtara Biotherapeutics, Inc.Newell JoeChief Tech. Operations OfficerS - Sale+OE$39.45-1,50031,858-4%-$59,178
M
2018-08-31
LIFEAtyr Pharma IncSchimmel PaulDirP - Purchase$0.74+42,7491,497,331+3%+$31,461
D
2018-08-31
EDITEditas Medicine, Inc.Hack Andrew A. F.CFOS - Sale+OE$32.23-10,0000-100%-$322,300
D
2018-08-31
HSKAHeska CorpLippincott RodEVP, Comp. Animal Health SalesS - Sale+OE$104.00-6,3718,573-43%-$662,584
D
2018-08-30
BLUEBluebird Bio, Inc.Walsh Jeffrey T.Chief FinancialS - Sale+OE$175.40-20,00035,495-36%-$3,507,948
2018-08-29
ADAPAdaptimmune Therapeutics PlcBinder-Scholl Gwendolyn KnowltonCTOS - Sale$10.25-25,0000-100%-$256,250
D
2018-08-30
XLRNAcceleron Pharma IncMcLaughlin Kevin FSVP, CFO, TreasurerS - Sale+OE$54.00-12,50043,939-22%-$675,000
2018-08-29
DNLIDenali Therapeutics Inc.Ho CaroleChief Medical OfficerS - Sale$18.04-17,500290,265-6%-$315,700
2018-08-29
DNLIDenali Therapeutics Inc.Watts Ryan J.Pres, CEOS - Sale$18.05-18,3342,796,809-1%-$330,929
2018-08-29
CHRSCoherus Biosciences, Inc.Healy JamesDirS - Sale$20.50-25,0002,868,221-1%-$512,500
D
2018-08-29
RGENRepligen CorpBarthelemy NicolasDirS - Sale+OE$54.44-6,5804,186-61%-$358,196
M
2018-08-29
LIFEAtyr Pharma IncSchimmel PaulDirP - Purchase$0.74+164,4111,454,582+13%+$121,573
2018-08-27
SGENSeattle Genetics Inc /waSimpson Todd ECFOS - Sale$74.23-5,427173,565-3%-$402,856
2018-08-27
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale$74.23-25,514636,632-4%-$1,893,950
2018-08-27
SGENSeattle Genetics Inc /waLiu Jean IGC, EVP, Leg AffairsS - Sale$74.23-4,12356,741-7%-$306,058
2018-08-27
SGENSeattle Genetics Inc /waHimes Vaughn BChief Technical OfficerS - Sale$74.23-5,530159,376-3%-$410,502
2018-08-27
SGENSeattle Genetics Inc /waCline Darren SEVP, CommercialS - Sale$74.23-4,78465,079-7%-$355,125
D
2018-08-27
ECLEcolab Inc.Higgins Arthur JDirS - Sale+OE$149.76-8,70016,863-34%-$1,302,947
D
2018-08-27
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale+OE$66.46-7,510341,020-2%-$499,118
2018-08-28
RGENRepligen CorpSnodgres JonCFOS - Sale$52.79-14,46020,899-41%-$763,359
D
2018-08-27
AERIAerie Pharmaceuticals IncMitro Thomas APres, COOS - Sale+OE$60.27-190,00051,479-79%-$11,451,006
D
2018-08-27
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.Pres, CEOP - Purchase$1.59+3,14197,604+3%+$5,000
2018-08-27
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$1.46+1,500705,3420%+$2,190
DM
2018-08-27
HSKAHeska CorpAsakowicz SteveEVP, Comp. Animal Health SalesS - Sale+OE$101.03-8,0008,400-49%-$808,247
D
2018-08-24
TECHBio-Techne CorpBaumgartner Robert VDirS - Sale+OE$188.47-5,0007,712-39%-$942,334
M
2018-08-24
HALOHalozyme Therapeutics IncKirk Randal J10%S - Sale$18.08-644,99814,092,771-4%-$11,663,346
D
2018-08-27
MNTAMomenta Pharmaceuticals IncStoner ElizabethDirS - Sale+OE$27.33-4,15229,639-12%-$113,474
M
2018-08-23
NKNantkwest, Inc.Gorlin SteveDirS - Sale$3.07-50,000518,000-9%-$153,513
DM
2018-08-23
HSKAHeska CorpLippincott RodEVP, Comp. Animal Health SalesS - Sale+OE$104.01-2,8058,573-25%-$291,743
D
2018-08-23
TECHBio-Techne CorpHiggins John LDirS - Sale+OE$187.92-10,0003,012-77%-$1,879,173
2018-08-22
RGENRepligen CorpRyan Thomas F JrDirS - Sale$51.44-2,3664,988-32%-$121,698
2018-08-21
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale$74.95-25,000662,146-4%-$1,873,750
M
2018-08-21
HALOHalozyme Therapeutics IncKirk Randal J10%S - Sale$17.65-1,194,46214,737,769-7%-$21,085,138
2018-08-21
MNTAMomenta Pharmaceuticals IncKwon YoungSVP, Corporate DevelopmentS - Sale$27.25-528111,3430%-$14,388
2018-08-21
MNTAMomenta Pharmaceuticals IncKaundinya Ganesh VenkataramanCOO, CSOS - Sale$27.25-581495,1450%-$15,832
2018-08-21
MNTAMomenta Pharmaceuticals IncLeicher BruceSVP, GCS - Sale$27.25-350171,8010%-$9,538
2018-08-21
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale$27.43-1,969582,0810%-$54,010
M
2018-08-20
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$36.37-7,800886,891-1%-$283,647
2018-08-20
EDITEditas Medicine, Inc.Bosley KatrinePres, CEOS - Sale$30.17-12,0001,264,966-1%-$362,008
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top